Cited by 31

The DOI matches its Crossref record.

Cutting Edge: Dab2 Is a FOXP3 Target Gene Required for Regulatory T Cell Function

Jain, Nitya, Nguyen, Hai, Friedline, Randall H, Malhotra, Nidhi, Brehm, Michael, Koyanagi, Madoka, Bix, Mark, Cooper, Jonathan A, Chambers, Cynthia A, Kang, Joonsoo·2009·The Journal of Immunology

Abstract

FOXP3-expressing regulatory T (Treg) cells are vital for maintaining peripheral T cell tolerance and homeostasis. The mechanisms by which FOXP3 target genes orchestrate context-dependent Treg cell function are largely unknown. In this study we show that in mouse peripheral lymphocytes the Drosophila Disabled-2 (Dab2) homolog, a gene that is involved in enhancing TGFβ responses, is exclusively expressed in FOXP3+ regulatory T cells. Dab2 is a direct target of FOXP3, and regulatory T cells lacking DAB2 are functionally impaired in vitro and in vivo. However, not all aspects of Treg cell function are perturbed, and DAB2 appears to be dispensable for Treg cell function in maintaining naive T cell homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0902041

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dab2 null Treg cells have no obvious phenotype in vivo.

    “Immune system/Treg | No obvious phenotype in vivo; failed to suppress T cells”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Jain et al., 2009

    In Results and Discussion, Dab2 conditional-knockout mice appeared healthy, lacked overt autoimmunity, and had phenotypically similar Treg cells under unperturbed conditions. But the same section reports an in vivo defect: their Treg cells failed to moderate established colitis. Thus, 'no obvious phenotype in vivo' is supported only for the unperturbed mice, not as a general statement about Treg function in vivo. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Mice with Dab2 deletion in Treg cells are healthy and do not show phenotypes related to autoimmunity defects even at 1 year of age, indicating that Dab2 is dispensable for Treg cells in maintaining T cell tolerance.

    “However, mice with Dab2 deletion in Treg cells are healthy in appearance and do not show phenotypes related to autoimmunity defects even at 1 year of age, indicating that the Dab2 is dispensable for Treg cells in maintaining T cell tolerance (Jain et al., 2009).”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Jain et al., 2009

    The Results and Discussion section reports that Dab2-deficient mice appeared healthy and had no overt autoimmunity at 10–12 months, suggesting that their Treg cells maintained naïve T cell tolerance. The claim omits that qualifier: the same section reports that Dab2-deficient Treg cells failed to control established colitis, so the paper does not establish that Dab2 is dispensable for Treg-mediated tolerance generally. Page numbers are not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Dab2 null Treg cells fail to suppress T cells.

    “Immune system/Treg | No obvious phenotype in vivo; failed to suppress T cells”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Jain et al., 2009

  • Dab2-deficient Treg cells failed to alleviate established colitis, suggesting a role of Dab2 in regulating lymphocyte infiltration and accumulation in the colon.

    “In additional analysis, it was observed that Dab2-deficient Treg cells failed to alleviate established colitis, suggesting a role of Dab2 in regulating lymphocyte infiltration and accumulation in the colon.”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Jain et al., 2009

  • Dab2 gene deletion was reported to affect regulatory T cell (Treg) function.

    “Dab2 gene deletion was reported to affect regulatory T cell (Treg) function (Jain et al., 2009).”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Jain et al., 2009

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 23

  1. 2003, Control of regulatory T cell development by the transcription factor Foxp3., 1057
  2. 2001, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3., 20
  3. 2007, Foxp3-dependent programme of regulatory T-cell differentiation., 771
  4. 2008, CTLA-4 control over Foxp3+ regulatory T cell function., 271
  5. 2009, CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance., 421
  6. 2006, FOXP3 controls regulatory T cell function through cooperation with NFAT., 375
  7. 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function., 566
  8. 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein., 80
  9. 2001, The adaptor molecule Disabled-2 links the transforming growth factor β receptors to the Smad pathway., 2789
  10. 2005, Disabled-2 (Dab2) is required for transforming growth factor β-induced epithelial to mesenchymal transition (EMT)., 17540
  11. 2007, Internalization of large double-membrane intercellular vesicles by a clathrin-dependent endocytic process., 337
  12. 2001, Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2., 111
  13. 1999, Differential expression of mouse Disabled 2 gene in retinoic acid-treated F9 embryonal carcinoma cells and early mouse embryos., 179
  14. 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3., 1875
  15. 2007, Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid., 256
  16. 2002, Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport., 1555
  17. 2001, A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival., 763
  18. 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells., 235
  19. 2003, Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10., 971
  20. 2007, Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression., 1303
  21. 2006, Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation., 256
  22. 2007, TGFβ signalling in control of T-cell-mediated self-reactivity., 443
  23. 2007, Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature., 786

Cited by

Sorted by citations

Metadata

Authors
Jain, N., Nguyen, H., Friedline, R. H., Malhotra, N., Brehm, M., Koyanagi, M., Bix, M., Cooper, J. A., Chambers, C. A., & Kang, J.
Affiliations
  • Department of Pathology, Graduate Program in Immunology and Virology, University of Massachusetts Medical School , Worcester, MA 01655
  • Department of Immunology, St. Jude Children’s Research Hospital , Memphis, TN 38105
  • Division of Basic Sciences, Fred Hutchinson Cancer Research Center , Seattle, WA 98109
Venue
The Journal of Immunology
Published
2009-10-01
Volume
183
Issue
7
Pages
4192-4196
ISSN
  • 1550-6606
  • 0022-1767
Cited by
31
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review